The global epigenetic antibodies market size is calculated at USD 2.70 billion in 2025 and is expected to reach around USD 12.01 billion by 2034, growing at a CAGR of 18.04% for the forecasted period.
GEAC and RCGM remain robust, science-driven regulatory bodies committed to biosafety and public interest; constructive ...
A head-to-head study by Israel's Technion found that CollPlant's rhCollagen-based bioink, Collink.3D™, outperformed Matrigel® ...
CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetic medicine company developing disruptive technologies and products based on its proprietary, non-animal recombinant human collagen ...
An update from Collplant Holdings ( ($CLGN) ) is now available. On October 16, 2025, CollPlant Biotechnologies announced the development of a ...
DENVER, Oct. 17, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market ...
US researchers create microscopic DNA “flowers” that mimic life, folding and unfolding to adapt and deliver medicine.
Experts warn of AI extinction risks. However, history shows past predictions of doom, like resource scarcity and nuclear ...
St. Jude researchers advance CASTs, enhancing precision and activity for next-generation genome-editing therapies.
Long interspersed nuclear element-1 (LINE-1 or L1) is the only active, self-copying genetic element in the human ...
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic ...
Synthetic biology has traditionally focused on model microorganisms like Escherichia coli and Saccharomyces cerevisiae.